Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
GEL
**HOW TO USE THIS MEDICINAL PRODUCT** **Dosage** On average, 1 drop 1 to 4 times a day. **Mode and route of administration** Local application OCULAR INSTILLATION. - Wash your hands thoroughly before handling the product. - To allow the formation of a drop of gel, the vial should be shaken before each utilization, and then squeezed gently. - Pulling the lower eyelid down and looking up, place a drop in the inner corner of the eye. - Do not touch the eye with the bottle tip. - Close the bottle after use. - After instillation, the bottle should be kept vertically with the cap downwards, to facilitate the formation of drops when next used. **Frequency and times of administration of the medicinal product** Space out the instillations throughout the day according to need. **Duration of treatment** If symptoms persist or worsen, consult an ophthalmologist, who will adjust your treatment.
OPHTHALMIC
Medical Information
**CASES IN WHICH THIS MEDICINAL PRODUCT SHOULD BE USED (THERAPEUTIC INDICATIONS)** This medicinal product is indicated for the symptomatic treatment of dry eye syndrome.
**WARNING ! CASES IN WHICH THIS MEDICINAL PRODUCT SHOULD NOT BE USED (CONTRAINDICATIONS)** Allergy to any of its components _IN DOUBT SEEK ADVICE FROM YOUR DOCTOR OR PHARMACIST._
S01XA20
artificial tears and other indifferent preparations
Manufacturer Information
DCH AURIGA SINGAPORE
URSAPHARM ARZNEIMITTEL GMBH & CO KG
Active Ingredients
Documents
Package Inserts
Siccafluid.pdf
Approved: March 9, 2005